Dividend Investing Ideas Center
Critical Facts You Need to Know About Preferred Stocks
Have you ever wished for the safety of bonds, but the return potential...
Name
As of 12/03/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
YTD Return
-3.5%
1 yr return
8.0%
3 Yr Avg Return
-2.7%
5 Yr Avg Return
0.8%
Net Assets
$1.73 B
Holdings in Top 10
31.8%
Expense Ratio 1.52%
Front Load N/A
Deferred Load N/A
Turnover 62.00%
Redemption Fee N/A
Standard (Taxable)
$1,000
IRA
$1,000
Fund Type
Open End Mutual Fund
Name
As of 12/03/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Under normal market conditions, the Fund invests at least 80% of its net assets (plus borrowings for investment purposes) in equity and equity-related securities of companies in the healthcare and life sciences sectors, including common stock, options, preferred stock and convertible debt. Healthcare and life sciences companies include those companies that derive or are expected to derive 50% or more of their revenue from healthcare and life science products and services including, but not limited to, biotechnology, pharmaceuticals, diagnostics, life science tools, medical devices, healthcare information technology, healthcare services, synthetic biology, agricultural and environmental management, and pharmaceutical manufacturing products and services. These companies may include private and other companies whose securities may have legal or contractual restrictions on resale or are otherwise illiquid (Illiquid Investments), which can impact their valuation. The Fund will not invest more than 15% of the Funds net assets in Illiquid Investments. These companies may include development stage companies. The Fund may invest without limitation in securities of companies domiciled outside the United States either directly or through American Depositary Receipts (ADRs). The Fund may invest in securities of companies of any market capitalization.
The Funds investment adviser, Eventide Asset Management, LLC (Eventide or the Adviser) utilizes a fundamental bottom-up analysis to evaluate investments for inclusion in the Funds portfolio. The Adviser seeks to invest in attractively valued securities that, in its opinion, represent above-average long-term investment opportunities or have significant near-term appreciation potential and that are capable of serving well the needs of customers, employees, suppliers, communities, the environment, and society broadly. The Adviser favors investments that it believes will have relatively low correlation to the overall market. The valuation of these investments may respond dramatically to clinical trial outcomes or regulatory decisions, providing atypical upside or downside volatility.
The Adviser uses options strategies, such as calls, covered calls, and puts on individual securities, as well as options on securities indices, to enhance returns, generate income, to reduce portfolio volatility, or to reduce downside risk when the Adviser believes adverse market, political or other conditions are likely. The Adviser may also utilize a combination of puts and/or calls on the same security (sometimes referred to as straddles, collars or spreads) or utilize puts and calls on related securities. The Adviser only makes use of these derivative strategies where the derivatives underlying security is within or related to the sectors in which the Fund normally invests.
The Fund concentrates investments in drug-related industries by investing, under normal circumstances, over 25% of its assets in drug-related industries. This group of industries includes pharmaceutical, biotech and similar companies that primarily develop, produce or distribute drugs, medicines, diagnostic chemicals and biological products used to diagnose, prevent or treat diseases or maintain health.
The Adviser uses its proprietary values-based screening methodology to analyze all potential investments for the companys ability to operate with integrity and create value for customers, employees, and other stakeholders by reflecting the values described below. The values assessed in the Advisers values-based screening process are inspired by the Christian faith and rooted in a biblical worldview. While few companies may reach these ideals in every area of their business, these principles articulate the Advisers highest expectations for the companies in which the Fund invests. The Adviser uses its values-based screening processes in connection with other fundamental research processes to establish the Funds eligible investment universe. Securities are generally ineligible within the Funds portfolio unless the Adviser believes that the values-based screens are met. If the Advisers research identifies events and/or business changes suggesting that a portfolio company no longer meets the values-based criteria, the Fund may hold the companys securities while the Adviser performs additional research, including possible direct engagement with the company to assess values-based practices. The Advisers screening process for potential investments does not apply relative weights between values-based factors and financial factors. There is no guarantee that the Adviser will be able to successfully screen out all companies that are inconsistent with the following principles which help to guide the Advisers research and investment framework. Specifically, the Adviser seeks to invest in companies that reflect the following values:
■ | Respecting the value and freedom of all people: this includes the right to life at all stages and freedom from addictive behaviors caused by gambling, pornography, tobacco, and alcohol. |
■ | Demonstrating a concern for justice and peace: this includes fair and ethical relationships with customers, suppliers, and business partners and avoiding products and services that promote weapons production and proliferation. |
■ | Promoting family and community: this includes protecting children from violent forms of entertainment and serving low-income communities. |
■ | Exhibiting responsible management practices: this includes fair dealing with employees, communities, competitors, suppliers, and customers as demonstrated by a companys record regarding litigation, regulatory actions against the company, and its record of providing products and services that improve the lives of people. |
■ | Practicing environmental stewardship: this includes practices considered more sustainable than those of industry peers, reduction in environmental impact when compared to previous periods, and/or the use of more efficient and cleaner energy sources. |
Consistent with the Advisers values, the Fund may invest in domestic and/or foreign fixed-income securities, such as notes (including standalone notes not rated by any agency), to help fund community development institutions and projects aimed at serving human needs such as those of low-to-moderate income families and communities.
Securities may be sold when the Adviser believes that they no longer represent relatively attractive investment opportunities or when the Adviser believes the underlying companys practices are no longer consistent with the Advisers values.
Period | ETNHX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | -3.5% | -18.7% | 22.6% | 94.97% |
1 Yr | 8.0% | -8.1% | 44.8% | 83.02% |
3 Yr | -2.7%* | -22.8% | 12.3% | 83.55% |
5 Yr | 0.8%* | -8.3% | 12.6% | 90.41% |
10 Yr | 9.1%* | -0.2% | 12.9% | 18.02% |
* Annualized
Period | ETNHX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | 10.8% | -12.6% | 19.0% | 8.18% |
2022 | -19.8% | -53.9% | 3.2% | 84.21% |
2021 | -25.3% | -39.6% | 24.2% | 93.42% |
2020 | 32.1% | -13.6% | 178.2% | 12.08% |
2019 | 55.0% | 3.8% | 63.8% | 2.26% |
Period | ETNHX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | -3.5% | -18.7% | 22.6% | 94.97% |
1 Yr | 8.0% | -8.1% | 44.8% | 83.02% |
3 Yr | -2.7%* | -22.8% | 12.3% | 83.55% |
5 Yr | 0.8%* | -8.3% | 12.6% | 90.41% |
10 Yr | 9.1%* | -0.2% | 12.9% | 18.02% |
* Annualized
Period | ETNHX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | 10.8% | -12.6% | 19.0% | 13.84% |
2022 | -19.8% | -53.9% | 3.7% | 86.84% |
2021 | -16.8% | -33.9% | 26.0% | 92.76% |
2020 | 36.8% | -0.7% | 180.6% | 19.46% |
2019 | 58.4% | 4.6% | 63.8% | 2.26% |
ETNHX | Category Low | Category High | ETNHX % Rank | |
---|---|---|---|---|
Net Assets | 1.73 B | 6.66 M | 45.7 B | 33.33% |
Number of Holdings | 93 | 25 | 430 | 44.65% |
Net Assets in Top 10 | 475 M | 2.12 M | 23.9 B | 41.51% |
Weighting of Top 10 | 31.80% | 18.4% | 78.1% | 90.57% |
Weighting | Return Low | Return High | ETNHX % Rank | |
---|---|---|---|---|
Stocks | 91.58% | 89.92% | 106.13% | 91.82% |
Preferred Stocks | 4.34% | 0.00% | 7.86% | 4.40% |
Cash | 3.84% | 0.00% | 33.01% | 32.70% |
Bonds | 0.03% | 0.00% | 12.39% | 20.13% |
Other | 0.00% | -22.99% | 23.24% | 65.41% |
Convertible Bonds | 0.00% | 0.00% | 0.37% | 50.65% |
Weighting | Return Low | Return High | ETNHX % Rank | |
---|---|---|---|---|
Healthcare | 100.00% | 59.26% | 100.00% | 25.97% |
Utilities | 0.00% | 0.00% | 0.00% | 46.75% |
Technology | 0.00% | 0.00% | 22.69% | 50.00% |
Real Estate | 0.00% | 0.00% | 5.89% | 49.35% |
Industrials | 0.00% | 0.00% | 7.02% | 50.00% |
Financial Services | 0.00% | 0.00% | 1.60% | 62.99% |
Energy | 0.00% | 0.00% | 0.00% | 46.75% |
Communication Services | 0.00% | 0.00% | 9.11% | 50.00% |
Consumer Defense | 0.00% | 0.00% | 25.73% | 53.90% |
Consumer Cyclical | 0.00% | 0.00% | 1.92% | 49.35% |
Basic Materials | 0.00% | 0.00% | 7.16% | 64.94% |
Weighting | Return Low | Return High | ETNHX % Rank | |
---|---|---|---|---|
US | 91.58% | 61.27% | 104.41% | 55.35% |
Non US | 0.00% | 0.00% | 34.10% | 85.53% |
Weighting | Return Low | Return High | ETNHX % Rank | |
---|---|---|---|---|
Corporate | 55.30% | 0.00% | 81.57% | 5.80% |
Cash & Equivalents | 3.72% | 0.00% | 100.00% | 32.08% |
Derivative | 0.00% | -0.01% | 23.24% | 56.60% |
Securitized | 0.00% | 0.00% | 0.00% | 45.65% |
Municipal | 0.00% | 0.00% | 0.00% | 45.65% |
Government | 0.00% | 0.00% | 29.44% | 46.38% |
Weighting | Return Low | Return High | ETNHX % Rank | |
---|---|---|---|---|
US | 0.03% | 0.00% | 11.75% | 20.13% |
Non US | 0.00% | 0.00% | 3.33% | 47.17% |
ETNHX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 1.52% | 0.08% | 4.48% | 32.08% |
Management Fee | 1.10% | 0.03% | 1.25% | 95.60% |
12b-1 Fee | 0.20% | 0.00% | 1.00% | 19.48% |
Administrative Fee | N/A | 0.03% | 0.25% | 34.69% |
ETNHX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 3.50% | 5.75% | N/A |
Deferred Load | N/A | 1.00% | 1.00% | N/A |
ETNHX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 1.00% | 87.50% |
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
ETNHX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 62.00% | 0.00% | 238.00% | 77.04% |
ETNHX | Category Low | Category High | ETNHX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.00% | 0.00% | 6.24% | 65.41% |
ETNHX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Annual | Annual | Annual | Annual |
ETNHX | Category Low | Category High | ETNHX % Rank | |
---|---|---|---|---|
Net Income Ratio | -1.47% | -2.54% | 1.85% | 95.39% |
ETNHX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Annually | Semi-Annually | Annually |
Date | Amount | Type |
---|---|---|
Dec 16, 2021 | $0.628 | OrdinaryDividend |
Dec 16, 2021 | $0.119 | CapitalGainShortTerm |
Dec 16, 2021 | $3.613 | CapitalGainLongTerm |
Dec 17, 2020 | $0.065 | CapitalGainShortTerm |
Dec 17, 2020 | $1.872 | CapitalGainLongTerm |
Dec 17, 2019 | $0.251 | CapitalGainShortTerm |
Dec 17, 2019 | $0.619 | CapitalGainLongTerm |
Dec 18, 2018 | $1.111 | CapitalGainShortTerm |
Dec 18, 2018 | $0.865 | CapitalGainLongTerm |
Dec 19, 2017 | $0.371 | CapitalGainLongTerm |
Dec 22, 2015 | $0.293 | CapitalGainLongTerm |
Start Date
Tenure
Tenure Rank
Dec 27, 2012
9.43
9.4%
Finny Kuruvilla, M.D., Ph.D., has been primarily responsible for the day-to-day management of the Gilead Fund and Healthcare & Life Sciences Fund since inception. Dr. Kuruvilla has been the Managing Partner of the Adviser since its inception in 2008. Dr. Kuruvilla possesses a diverse background in quantitative methods, with applications focused on innovations in science, engineering, and medicine. He holds an MD from Harvard Medical School, a PhD in Chemistry and Chemical Biology from Harvard University, a master’s degree in Electrical Engineering and Computer Science from MIT, and a bachelor’s degree from Caltech in Chemistry. From 2005-2008, Dr. Kuruvilla was a clinical fellow at the Brigham and Women's Hospital and a postdoctoral scientist at MIT. As an avid proponent of values-based investing, Dr. Kuruvilla has established rigorous standards in seeking out the most ethical companies at the outset of the stock selection process. In addition to his role with the Adviser, Dr. Kuruvilla is a founder, financial sponsor, and Board Director of Sattler College, a four-year college in Boston, Massachusetts, opened in 2018. Dr. Kuruvilla also contributes to the college in a limited faculty role. From 2008-2016, Dr. Kuruvilla provided research services as an employee of Clarus Ventures, a healthcare and life sciences venture capital firm. From 2006-2008, Dr. Kuruvilla was a research fellow at the Broad Institute of Harvard and MIT.
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.02 | 24.72 | 7.88 | 0.25 |
Dividend Investing Ideas Center
Have you ever wished for the safety of bonds, but the return potential...
Dividend Investing Ideas Center
If you are reaching retirement age, there is a good chance that you...
Dividend Investing Ideas Center
If you are reaching retirement age, there is a good chance that you...